Emerging research supports peptides as a low-risk, high-reward option for individuals seeking long-term fat loss and metabolic optimization
Semaglutide belongs to a class of drugs called GLP-1 receptor agonists
The quality of the studies evaluated can be seen in Supplementary Figure 1
6 Data shows that White patients are 4 times more likely than Black patients to receive a semaglutide prescription, despite higher rates of obesity and diabetes in Black and Hispanic communities
Credibility, quality, bias, and ethics: necessary checks before use in pharmacovigilance
Additionally, benefits like lowering blood pressure, improving lipid disorders, improving fatty liver disease, reducing your risk of heart disease and kidney disease, and delaying the progression of diabetes-related nephropathy, have been documented